This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> BioCryst Pharma (BCRX) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $16
> Danske Bank A/S (DNKEY) upgraded to Buy from Hold at Deutsche Bank
> Denali Therapeutics (DNLI) upgraded to Buy from Neutral at BTIG Research; tgt $38
> KKR (KKR) upgraded to Buy from Neutral at BofA Securities; tgt raised to $60
> Premier (PINC) upgraded to Outperform from Neutral at Robert W. Baird; tgt $41
Downgrades:
> Avista (AVA) downgraded to Neutral from Buy at Mizuho; tgt lowered to $40
> Blueprint Medicines (BPMC) downgraded to Perform from Outperform at Oppenheimer
> Catalent (CTLT) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $60
> Iberdrola SA (IBDRY) downgraded to Equal-Weight from Overweight at Morgan Stanley
> Ocado (OCDGF) downgraded to Underweight from Neutral at JP Morgan
> SeaSpine (SPNE) downgraded to Hold from Buy at Truist; tgt lowered to $6.75
> Twilio (TWLO) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $85
Others:
> Cronos Group (CRON) initiated with a Mkt Perform at Bernstein; tgt $3
> Denali Therapeutics (DNLI) initiated with a Buy at BofA Securities; tgt $40
> OneSpaWorld (OSW) initiated with a Buy at Truist; tgt $12
> Tilray (TLRY) initiated with a Mkt Perform at Bernstein; tgt $3.90
Research calls posted earlier this morning are available here.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
